Why did Novavax stock rise today?
Novavax (NVAX +8.0%) shares have approached a two-month high extending the recent gains to the fourth straight session.
Just last week, an Indian manufacturer of the company’s protein-based COVID-19 shot was allowed by the government there to export 20M doses of the vaccine to Indonesia.
The upward momentum of Novavax (NASDAQ:NVAX) has also coincided with the regulatory clearance for the COVID-19 booster shots in the U.S. allowing their use in a wider segment of vaccine recipients last week.
However, among vaccine makers, Moderna (MRNA +7.2%) and BioNTech (BNTX +11.0%) have led the gainers.
Rising more than a tenth in value, BioNTech (NASDAQ:BNTX), the partner of Pfizer (PFE +0.8%) in COVID-19 vaccine development has gained for the ninth consecutive session.
Meanwhile, Moderna (NASDAQ:MRNA) has added the biggest intraday gain since early September paring back the losses made this month after revising down the sales projection for its COVID-19 vaccine.
Source: https://seekingalpha.com/news/3773518-why-did-novavax-stock-rise-today
My thoughts, with any approval from countrieswill just rocket the stock even further. Because it is a much safer approach as it is protein based.
精彩评论